Skip to content
Neuropediatoolkit

Neuropediatoolkit

  • Toolkit
  • Clinical guidelines
  • Referral criteria
  • School
  • Lab
  • Archive
  • About
  • Login & Registration

PTEN.

Posted byAlberto Alcantud September 11, 2022June 22, 2026

PHTS Foundation.

Posted byAlberto AlcantudSeptember 11, 2022June 22, 2026Posted inOncological risk

Post navigation

Previous post Previous post:
Neurofibromatosis type 1.
Next post Next post:
Neurogenetic disorders and oncological risk.
Neuropediatoolkit, Proudly powered by WordPress.
English
Spanish German French Russian Chinese Japanese